National Institute of Public Health and the Environment - RIVM, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.
Inspectorate for Health Protection, Commodities and Veterinary Public Health, De Stoven 22, 7206 AX Zutphen, The Netherlands.
Altern Lab Anim. 1999 Jan-Feb;27(1):79-102. doi: 10.1177/026119299902700106.
This is the report of the thirty-fifth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM's main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures which would enable it to become well informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of various types of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). This joint ECVAM/FELASA (Federation of European Laboratory Animal Science Associations) workshop on The Immunisation of Laboratory Animals for the Production of Polyclonal Antibodies was held in Utrecht (The Netherlands), on 20-22 March 1998, under the co-chairmanship of Coenraad Hendriksen (RIVM, Bilthoven, The Netherlands) and Wim de Leeuw (Inspectorate for Health Protection, The Netherlands). The participants, all experts in the fields of immunology, laboratory animal science, or regulation, came from universities, industry and regulatory bodies. The aims of the workshop were: a) to discuss and evaluate current immunisation procedures for the production of polyclonal antibodies (including route of injection, animal species and adjuvant ); and b) to draft recommendations and guidelines to improve the immunisation procedures, with regard both to animal welfare and to the optimisation of immunisation protocols. This report summarises the outcome of the discussions and includes a number of recommendations and a set of draft guidelines (included in Appendix 1).
这是由欧洲替代方法验证中心(ECVAM)组织的第 35 次系列研讨会报告。正如其科学顾问委员会在 1993 年所定义的,ECVAM 的主要目标是促进对生物科学重要的替代方法的科学和监管接受,这些方法减少、改进或取代了实验室动物的使用。ECVAM 设定的首要任务之一是实施程序,使它能够充分了解非动物测试开发和验证的最新情况,以及将替代测试纳入监管程序的潜力。决定通过组织关于特定主题的 ECVAM 研讨会来实现这一目标,在这些研讨会上,一小群受邀专家将审查各种类型的体外测试的现状及其潜在用途,并就前进的最佳方式提出建议(1)。此次关于“用于生产多克隆抗体的实验动物免疫接种”的 ECVAM/FELASA(欧洲实验动物科学协会联合会)联合研讨会于 1998 年 3 月 20 日至 22 日在荷兰乌得勒支举行,由 Coenraad Hendriksen(荷兰 RIVM,比尔特霍芬)和 Wim de Leeuw(荷兰卫生保护监察局)共同主持。与会者均为免疫学、实验动物科学或监管领域的专家,分别来自大学、工业界和监管机构。研讨会的目的是:a)讨论和评估用于生产多克隆抗体的当前免疫程序(包括注射途径、动物物种和佐剂);b)起草关于改善免疫程序的建议和指南,既要考虑动物福利,又要优化免疫方案。本报告总结了讨论的结果,包括一些建议和一套草案指南(见附录 1)。